• 10046 Citations
  • 53 h-Index
19992020
If you made any changes in Pure these will be visible here soon.

Research Output 1999 2020

Filter
Article
2020

Plasma Levels of C-Type Lectin REG3α and Gut Damage in People With Human Immunodeficiency Virus

Montreal Primary HIV Infection Study, the Canadian Cohort of HIV+ Slow Progressors, and the Canadian HIV and Aging Cohort Groups , jan. 1 2020, In : The Journal of infectious diseases. 221, 1, p. 110-121 12 p.

Research output: Article

C-Type Lectins
HIV
Comorbidity
Paneth Cells
Therapeutics
2019
Hungary
Crohn Disease
Databases
Biosimilar Pharmaceuticals
Pharmaceutical Preparations
7 Citations (Scopus)

Biosimilars for the management of inflammatory bowel diseases: Economic considerations

Gulácsi, L., Pentek, M., Rencz, F., Brodszky, V., Baji, P., Vegh, Z., Gecse, K. B., Danese, S., Peyrin-Biroulet, L. & Lakatos, P., jan. 1 2019, In : Current medicinal chemistry. 26, 2, p. 259-269 11 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Economics
Budgets
Health
2 Citations (Scopus)

Biosimilars in IBD: Will it benefit to patients, physicians or the health care system?

Gonczi, L., Ilias, A., Kurti, Z. & Lakatos, P., jan. 1 2019, In : Current pharmaceutical design. 25, 1, p. 13-18 6 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Delivery of Health Care
Physicians
Safety

Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?

Gonczi, L. & Lakatos, P., szept. 19 2019, In : Journal of Crohn's & colitis. 13, 9, p. 1095-1096 2 p.

Research output: Article

Nocebo Effect
Inflammatory Bowel Diseases
Inflammatory Bowel Diseases
Population
Ulcerative Colitis
Crohn Disease
Mesalamine
1 Citation (Scopus)

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic

Reinglas, J., Restellini, S., Gonczi, L., Kurti, Z., Verdon, C., Nene, S., Kohen, R., Afif, W., Bessissow, T., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., márc. 1 2019, In : Digestive and Liver Disease. 51, 3, p. 340-345 6 p.

Research output: Article

Quality of Health Care
Inflammatory Bowel Diseases
Referral and Consultation
Leukocyte L1 Antigen Complex
Drug Monitoring
2 Citations (Scopus)

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study

Côté-Daigneault, J., Bessissow, T., Nicolae, M. V., Nie, R., Bitton, A., Lakatos, P. & Brassard, P., ápr. 11 2019, In : Inflammatory bowel diseases. 25, 5, p. 914-918 5 p.

Research output: Article

Herpes Zoster
Inflammatory Bowel Diseases
Incidence
Population
Quebec

High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, while Rates of Dysplasia are Low before the Suggested Onset of Surveillance

Singh, K., Al Khoury, A., Kurti, Z., Gonczi, L., Reinglas, J., Verdon, C., Kohen, R., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1343-1350 8 p.

Research output: Article

Open Access
Ulcerative Colitis
Inflammatory Bowel Diseases
Crohn Disease
Colorectal Neoplasms
Guidelines
3 Citations (Scopus)

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival

Chao, C. Y., Al Khoury, A., Aruljothy, A., Restellini, S., Wyse, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., febr. 15 2019, In : Digestive Diseases and Sciences. 64, 2, p. 518-523 6 p.

Research output: Article

Colectomy
Ulcerative Colitis
Survival
Therapeutics
Infliximab
Social Adjustment
Arthralgia
Tertiary Care Centers
Pharmaceutical Preparations
Safety
1 Citation (Scopus)
Open Access
Self Efficacy
Inflammatory Bowel Diseases
Physicians
Ulcerative Colitis
Crohn Disease
12 Citations (Scopus)

Natural disease course of Crohn's disease during the first 5 years after diagnosis in a European population-based inception cohort: An Epi-IBD study

Burisch, J., Kiudelis, G., Kupcinskas, L., Kievit, H. A. L., Andersen, K. W., Andersen, V., Salupere, R., Pedersen, N., Kjeldsen, J., D'Incà, R., Valpiani, D., Schwartz, D., Odes, S., Olsen, J., Nielsen, K. R., Vegh, Z., Lakatos, P., Toca, A., Turcan, S., Katsanos, K. H. & 26 others, Christodoulou, D. K., Fumery, M., Gower-Rousseau, C., Zammit, S. C., Ellul, P., Eriksson, C., Halfvarson, J., Magro, F. J., Duricova, D., Bortlik, M., Fernandez, A., Hernández, V., Myers, S., Sebastian, S., Oksanen, P., Collin, P., Goldis, A., Misra, R., Arebi, N., Kaimakliotis, I. P., Nikuina, I., Belousova, E., Brinar, M., Cukovic-Cavka, S., Langholz, E. & Munkholm, P., márc. 1 2019, In : Gut. 68, 3, p. 423-433 11 p.

Research output: Article

Crohn Disease
Population
Immunologic Factors
Eastern Europe
Biological Therapy
9 Citations (Scopus)

Natural Disease Course of Ulcerative Colitis during the First Five Years of Follow-up in a European Population-based Inception Cohort - An Epi-IBD Study

Burisch, J., Katsanos, K. H., Christodoulou, D. K., Barros, L., Magro, F., Pedersen, N., Kjeldsen, J., Vegh, Z., Lakatos, P., Eriksson, C., Halfvarson, J., Fumery, M., Gower-Rousseau, C., Brinar, M., Čuković-Čavka, S., Nikulina, I., Belousova, E., Myers, S., Sebastian, S., Kiudelis, G. & 27 others, Kupcinskas, L., Schwartz, D., Odes, S., Kaimakliotis, I. P., Valpiani, D., D'Incà, R., Salupere, R., Chetcuti Zammit, S., Ellul, P., Duricova, D., Bortlik, M., Goldis, A., Kievit, H. A. L., Toca, A., Turcan, S., Midjord, J., Nielsen, K. R., Andersen, K. W., Andersen, V., Misra, R., Arebi, N., Oksanen, P., Collin, P., De Castro, L., Hernandez, V., Langholz, E. & Munkholm, P., febr. 1 2019, In : Journal of Crohn's and Colitis. 13, 2, p. 198-208 11 p.

Research output: Article

Ulcerative Colitis
Population
Immunologic Factors
Biological Therapy
Colitis
4 Citations (Scopus)

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade

Ilias, A., Szanto, K., Gonczi, L., Kurti, Z., Golovics, P. A., Farkas, K., Schafer, E., Szepes, Z., Szalay, B., Vincze, A., Szamosi, T., Molnar, T. & Lakatos, P. L., nov. 2019, In : Clinical Gastroenterology and Hepatology. 17, 12, p. 2506-2513.e2

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Crohn Disease
Ulcerative Colitis
Therapeutics

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

Rencz, F., Stalmeier, P. F. M., Péntek, M., Brodszky, V., Ruzsa, G., Gönczi, L., Palatka, K., Herszényi, L., Schäfer, E., Banai, J., Rutka, M., Gulácsi, L. & Lakatos, P., jún. 1 2019, In : European Journal of Health Economics. 20, p. 91-100 10 p.

Research output: Article

Open Access
Crohn Disease
Health
Fistula
Population
Quality of Life
2 Citations (Scopus)

Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre

Gonczi, L., Kurti, Z., Verdon, C., Reinglas, J., Kohen, R., Morin, I., Chavez, K., Bessissow, T., Afif, W., Wild, G., Seidman, E., Bitton, A. & Lakatos, P., szept. 19 2019, In : Journal of Crohn's & colitis. 13, 9, p. 1138-1147 10 p.

Research output: Article

Open Access
Quality of Health Care
Inflammatory Bowel Diseases
Quality of Life
Prospective Studies
Phenotype
Crohn Disease
5 Citations (Scopus)

Risk Factors Associated with Clostridium difficile infection in inflammatory bowel disease: A systematic review and meta-analysis

Balram, B., Battat, R., Al-Khoury, A., D’Aoust, J., Afif, W., Bitton, A., Lakatos, P. & Bessissow, T., jan. 1 2019, In : Journal of Crohn's and Colitis. 13, 1, p. 27-38 12 p.

Research output: Article

Clostridium Infections
Clostridium difficile
Inflammatory Bowel Diseases
Meta-Analysis
Odds Ratio
2 Citations (Scopus)

Risk of Malignant Cancers in Inflammatory Bowel Disease

Loo, S. Y., Vutcovici, M., Bitton, A., Lakatos, P., Azoulay, L., Suissa, S. & Brassard, P., szept. 27 2019, In : Journal of Crohn's and Colitis. 13, 10, p. 1302-1310 9 p.

Research output: Article

Inflammatory Bowel Diseases
Confidence Intervals
Quebec
Incidence
Odds Ratio
10 Citations (Scopus)

Screening for nonalcoholic fatty liver disease in inflammatory bowel diseases: A cohort study using transient elastography

Saroli Palumbo, C., Restellini, S., Chao, C. Y., Aruljothy, A., Lemieux, C., Wild, G., Afif, W., Lakatos, P., Bitton, A., Cocciolillo, S., Ghali, P., Bessissow, T. & Sebastiani, G., jan. 1 2019, In : Inflammatory bowel diseases. 25, 1, p. 124-133 10 p.

Research output: Article

Elasticity Imaging Techniques
Inflammatory Bowel Diseases
Cohort Studies
Liver Cirrhosis
Odds Ratio
2 Citations (Scopus)

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives

Bitton, A., Vutcovici, M., Lytvyak, E., Kachan, N., Bressler, B., Jones, J., Lakatos, P., Sewitch, M., El-Matary, W., Melmed, G. & Nguyen, G., jan. 10 2019, In : Inflammatory bowel diseases. 25, 2, p. 403-409 7 p.

Research output: Article

Inflammatory Bowel Diseases
Physicians
Workflow
Quality of Health Care
Risk Management
4 Citations (Scopus)

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development

King, J. A., Underwood, F. E., Panaccione, N., Quan, J., Windsor, J. W., Kotze, P. G., Ng, S. C., Ghosh, S., Lakatos, P., Jess, T., Panaccione, R., Seow, C. H., Ben-Horin, S., Burisch, J., Colombel, J. F., Loftus, E. V., Gearry, R., Halfvarson, J. & Kaplan, G. G., ápr. 1 2019, In : The Lancet Gastroenterology and Hepatology. 4, 4, p. 287-295 9 p.

Research output: Article

Inflammatory Bowel Diseases
Developed Countries
Hospitalization
Population
Organisation for Economic Co-Operation and Development
2 Citations (Scopus)

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

Danese, S., Allez, M., Van Bodegraven, A. A., Dotan, I., Gisbert, J. P., Hart, A., Lakatos, P., Magro, F., Peyrin-Biroulet, L., Schreiber, S., Tarabar, D., Vavricka, S., Halfvarson, J. & Vermeire, S., ápr. 1 2019, In : Digestive Diseases. 37, 4, p. 266-283 18 p.

Research output: Article

Open Access
Ulcerative Colitis
Consensus
Group Processes
Inflammatory Bowel Diseases
PubMed
2018
12 Citations (Scopus)

Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

Goncalves, J., Santos, M., Acurcio, R., Iria, I., Gouveia, L., Matos Brito, P., Catarina Cunha-Santos, A., Barbas, A., Galvão, J., Barbosa, I., Aires da Silva, F., Alcobia, A., Cavaco, M., Cardoso, M., Delgado Alves, J., Carey, J. J., Dörner, T., Eurico Fonseca, J., Palmela, C., Torres, J. & 12 others, Lima Vieira, C., Trabuco, D., Fiorino, G., Strik, A., Yavzori, M., Rosa, I., Correia, L., Magro, F., D'Haens, G., Ben-Horin, S., Lakatos, P. & Danese, S., szept. 1 2018, In : Alimentary Pharmacology and Therapeutics. 48, 5, p. 507-522 16 p.

Research output: Article

Inflammatory Bowel Diseases
Epitopes
Serum
Anti-Idiotypic Antibodies
CT-P13
2 Citations (Scopus)

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease

Benmassaoud, A., Al-Taweel, T., Sasson, M. S., Moza, D., Strohl, M., Kopylov, U., Paradis-Surprenant, L., Almaimani, M., Bitton, A., Afif, W., Lakatos, P. & Bessissow, T., máj. 1 2018, In : Digestive Diseases and Sciences. 63, 5, p. 1302-1310 9 p.

Research output: Article

Biological Products
Crohn Disease
Adrenal Cortex Hormones
Infliximab
Adalimumab
8 Citations (Scopus)

Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

Baji, P., Gulácsi, L., Brodszky, V., Végh, Z., Danese, S., Irving, P. M., Peyrin-Biroulet, L., Schreiber, S., Rencz, F., Lakatos, P. & Péntek, M., márc. 1 2018, In : United European Gastroenterology Journal. 6, 2, p. 310-321 12 p.

Research output: Article

Biosimilar Pharmaceuticals
Crohn Disease
Cost-Benefit Analysis
Quality-Adjusted Life Years
Costs and Cost Analysis
30 Citations (Scopus)

Development of an index to define overall disease severity in IBD

Siegel, C. A., Whitman, C. B., Spiegel, B. M. R., Feagan, B., Sands, B., Loftus, E. V., Panaccione, R., D'Haens, G., Bernstein, C. N., Gearry, R., Ng, S. C., Mantzaris, G. J., Sartor, B., Silverberg, M. S., Riddell, R., Koutroubakis, I. E., O'Morain, C., Lakatos, P., McGovern, D. P. B., Halfvarson, J. & 16 others, Reinisch, W., Rogler, G., Kruis, W., Tysk, C., Schreiber, S., Danese, S., Sandborn, W., Griffiths, A., Moum, B., Gasche, C., Pallone, F., Travis, S., Panes, J., Colombel, J. F., Hanauer, S. & Peyrin-Biroulet, L., febr. 1 2018, In : Gut. 67, 2, p. 244-254 11 p.

Research output: Article

Crohn Disease
Inflammatory Bowel Diseases
Biological Products
C-Reactive Protein
Abscess
57 Citations (Scopus)

ECCO-ESCP consensus on surgery for Crohn's disease

on behalf of the European Crohn's and Colitis Organisation , jan. 1 2018, In : Journal of Crohn's and Colitis. 12, 1, p. 1-16 16 p.

Research output: Article

Open Access
Crohn Disease
Guidelines
3 Citations (Scopus)

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis–results from multicenter observational cohort

Bálint, A., Rutka, M., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Szepes, Z., Nagy, F., Palatka, K., Lovas, S., Végh, Z., Kürti, Z., Csontos, Á., Miheller, P., Nyári, T., Bor, R. & 6 others, Milassin, Á., Fábián, A., Szántó, K., Lakatos, P., Molnár, T. & Farkas, K., nov. 2 2018, In : Expert Opinion on Biological Therapy. 18, 11, p. 1181-1187 7 p.

Research output: Article

Biosimilar Pharmaceuticals
Ulcerative Colitis
Leukocyte L1 Antigen Complex
Antibodies
Azathioprine
1 Citation (Scopus)

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

Tornai, T., Tornai, D., Sipeki, N., Tornai, I., Alsulaimani, R., Fechner, K., Roggenbuck, D., Norman, G. L., Verès, G., Pár, G., Pár, A., Szalay, F., Lakatos, P., Antal-Szalmás, P. & Papp, M., dec. 1 2018, In : Scientific Reports. 8, 1, 399.

Research output: Article

Sclerosing Cholangitis
Immunity
Glycoproteins
Immunoglobulin A
Autoantibodies
3 Citations (Scopus)

Optimizing patient management in crohn’s disease in a tertiary referral center: The impact of fast-track mri on patient management and outcomes

Ilias, A., Lovasz, B. D., Gonczi, L., Kurti, Z., Vegh, Z., Sumegi, L. D., Golovics, P. A., Rudas, G. & Lakatos, P., dec. 1 2018, In : Journal of Gastrointestinal and Liver Diseases. 27, 4, p. 391-397 7 p.

Research output: Article

Open Access
Tertiary Care Centers
Crohn Disease
Magnetic Resonance Imaging
Biomarkers
Therapeutics
5 Citations (Scopus)

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies

Gonczi, L., Kurti, Z., Golovics, P. A., Lovasz, B. D., Menyhart, O., Seres, A., Sumegi, L. D., Gal, A., Ilias, A., Janos, P., Gecse, K. B., Bessisow, T., Afif, W., Bitton, A., Vegh, Z. & Lakatos, P., jan. 1 2018, In : Digestive and Liver Disease. 50, 1, p. 37-41 5 p.

Research output: Article

Quality of Health Care
Inflammatory Bowel Diseases
Tertiary Care Centers
Endoscopy
Gastroscopy
19 Citations (Scopus)

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases—Pooled Analysis of Population-Based Studies From Western Countries

Shah, S. C., Khalili, H., Gower-Rousseau, C., Olen, O., Benchimol, E. I., Lynge, E., Nielsen, K. R., Brassard, P., Vutcovici, M., Bitton, A., Bernstein, C. N., Leddin, D., Tamim, H., Stefansson, T., Loftus, E. V., Moum, B., Tang, W., Ng, S. C., Gearry, R., Sincic, B. & 8 others, Bell, S., Sands, B. E., Lakatos, P., Végh, Z., Ott, C., Kaplan, G. G., Burisch, J. & Colombel, J. F., okt. 1 2018, In : Gastroenterology. 155, 4, p. 1079-1089.e3

Research output: Article

Sex Characteristics
Inflammatory Bowel Diseases
Incidence
Ulcerative Colitis
Crohn Disease
6 Citations (Scopus)

Therapeutic drug monitoring guides the management of Crohn's patients with secondary loss of response to adalimumab

Restellini, S., Chao, C. Y., Lakatos, P., Aruljothy, A., Aziz, H., Kherad, O., Bitton, A., Wild, G., Afif, W. & Bessissow, T., jan. 1 2018, In : Inflammatory bowel diseases. 24, 7, p. 1531-1538 8 p.

Research output: Article

Drug Monitoring
Serum
Adalimumab
Equidae
Immunologic Factors
1 Citation (Scopus)

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn's diseases in the biological era in Hungary: A nationwide study based on the National Health Insurance Fund database

Kurti, Z., Ilias, A., Gonczi, L., Vegh, Z., Fadgyas-Freyler, P., Korponay, G., Golovics, P. A., Lovasz, B. D. & Lakatos, P., jan. 30 2018, In : BMC gastroenterology. 18, 1, 23.

Research output: Article

Open Access
Hungary
National Health Programs
Crohn Disease
Databases
Immunosuppressive Agents
2 Citations (Scopus)

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

Rencz, F., Lakatos, P., Gulácsi, L., Brodszky, V., Kürti, Z., Lovas, S., Banai, J., Herszényi, L., Cserni, T., Molnár, T., Péntek, M. & Palatka, K., jan. 1 2018, (Accepted/In press) In : Quality of Life Research.

Research output: Article

Crohn Disease
Visual Analog Scale
Psychometrics
Fistula
Cost-Benefit Analysis
2017
173 Citations (Scopus)
Open Access
Crohn Disease
Colitis
Publications
14 Citations (Scopus)

Access to biologicals in Crohn's disease in ten European countries

Crohn's Disease Research Group, szept. 14 2017, In : World Journal of Gastroenterology. 23, 34, p. 6294-6305 12 p.

Research output: Article

Gross Domestic Product
Crohn Disease
Biosimilar Pharmaceuticals
Sweden
Slovakia
10 Citations (Scopus)

Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe

Rencz, F., Gulácsi, L., Péntek, M., Gecse, K. B., Dignass, A., Halfvarson, J., Gomollón, F., Baji, P., Peyrin-Biroulet, L., Lakatos, P. & Brodszky, V., nov. 2 2017, In : Expert Review of Pharmacoeconomics and Outcomes Research. 17, 6, p. 597-606 10 p.

Research output: Article

Biosimilar Pharmaceuticals
Crohn Disease
Costs and Cost Analysis
Quality-Adjusted Life Years
Therapeutics
7 Citations (Scopus)

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

Gonczi, L., Kurti, Z., Rutka, M., Vegh, Z., Farkas, K., Lovasz, B. D., Golovics, P. A., Gecse, K. B., Szalay, B., Molnár, T. & Lakatos, P., aug. 8 2017, In : BMC Gastroenterology. 17, 1, 97.

Research output: Article

Drug Monitoring
Inflammatory Bowel Diseases
Pharmaceutical Preparations
Therapeutics
Hungary
89 Citations (Scopus)

ECCO Position statement on the use of biosimilars for inflammatory bowel disease-an update

Danese, S., Fiorino, G., Raine, T., Ferrante, M., Kemp, K., Kierkus, J., Lakatos, P., Mantzaris, G., van der Woude, J., Panes, J. & Peyrin-Biroulet, L., jan. 1 2017, In : Journal of Crohn's and Colitis. 11, 1, p. 26-34 9 p.

Research output: Article

Open Access
Biosimilar Pharmaceuticals
Drug Substitution
Gastrointestinal Agents
Inflammatory Bowel Diseases
Infliximab
9 Citations (Scopus)

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

Bálint, A., Rutka, M., Végh, Z., Kürti, Z., Gecse, K. B., Banai, J., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Patai, Á., Salamon, Á., Szamosi, T., Szepes, Z., Tóth, G. T., Vincze, Á., Bor, R., Milassin, Á. & 13 others, Fábián, A., Nagy, F., Kolar, M., Bortlik, M., Duricova, D., Hruba, V., Lukas, M., Mitrova, K., Malickova, K., Lukas, M., Lakatos, P., Molnár, T. & Farkas, K., aug. 3 2017, In : Expert Opinion on Drug Safety. 16, 8, p. 885-890 6 p.

Research output: Article

Biosimilar Pharmaceuticals
Inflammatory Bowel Diseases
Anti-Idiotypic Antibodies
Pharmaceutical Preparations
Therapeutics
10 Citations (Scopus)

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

Tornai, T., Palyu, E., Vitalis, Z., Tornai, I., Tornai, D., Antal-Szalmás, P., Norman, G. L., Shums, Z., Verès, G., Dezsofi, A., Pár, G., Pár, A., Orosz, P., Szalay, F., Lakatos, P. & Papp, M., aug. 7 2017, In : World Journal of Gastroenterology. 23, 29, p. 5412-5421 10 p.

Research output: Article

Sclerosing Cholangitis
Immunoglobulin A
Biomarkers
Immunoglobulin G
Enterocytes
12 Citations (Scopus)

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis–experiences from a single center

Farkas, K., Rutka, M., Ferenci, T., Nagy, F., Bálint, A., Bor, R., Milassin, Á., Fábián, A., Szántó, K., Végh, Z., Kürti, Z., Lakatos, P., Szepes, Z. & Molnár, T., nov. 2 2017, In : Expert Opinion on Biological Therapy. 17, 11, p. 1325-1332 8 p.

Research output: Article

Biosimilar Pharmaceuticals
Ulcerative Colitis
Crohn Disease
Therapeutics
Inflammatory Bowel Diseases
15 Citations (Scopus)

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab after One Year in a Prospective Nationwide Cohort

Gonczi, L., Gecse, K. B., Vegh, Z., Kurti, Z., Rutka, M., Farkas, K., Golovics, P. A., Lovasz, B. D., Banai, J., Bene, L., Gasztonyi, B., Kristof, T., Lakatos, L., Miheller, P., Nagy, F., Palatka, K., Papp, M., Patai, A., Salamon, A., Szamosi, T. & 6 others, Szepes, Z., Toth, G. T., Vincze, A., Szalay, B., Molnar, T. & Lakatos, P., nov. 1 2017, In : Inflammatory bowel diseases. 23, 11, p. 1908-1915 8 p.

Research output: Article

Biosimilar Pharmaceuticals
Crohn Disease
Ulcerative Colitis
Safety
Tumor Necrosis Factor-alpha
8 Citations (Scopus)
Open Access
Inflammatory Bowel Diseases
Anemia
Population
Ulcerative Colitis
Crohn Disease
21 Citations (Scopus)

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

Gonczi, L., Vegh, Z., Golovics, P. A., Rutka, M., Gecse, K. B., Bor, R., Farkas, K., Szamosi, T., Bene, L., Gasztonyi, B., Kristóf, T., Lakatos, L., Miheller, P., Palatka, K., Papp, M., Patai, Á., Salamon, Á., Tóth, G. T., Vincze, A., Biro, E. & 5 others, Lovasz, B. D., Kurti, Z., Szepes, Z., Molnár, T. & Lakatos, P., jún. 1 2017, In : Journal of Crohn's & colitis. 11, 6, p. 697-705 9 p.

Research output: Article

Biosimilar Pharmaceuticals
Area Under Curve
Biomarkers
Ulcerative Colitis
Crohn Disease
3 Citations (Scopus)

Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab

Vegh, Z., Kurti, Z. & Lakatos, P., febr. 1 2017, In : Digestive Diseases. 35, 1-2, p. 101-106 6 p.

Research output: Article

Biosimilar Pharmaceuticals
Safety
Remission Induction
Inflammatory Bowel Diseases
Maintenance
3 Citations (Scopus)

Systematic review and meta-Analysis of colon cleansing preparations in patients with inflammatory bowel disease

Restellini, S., Kherad, O., Bessissow, T., Ménard, C., Martel, M., Tanjani, M. T., Lakatos, P. & Barkun, A. N., aug. 28 2017, In : World journal of gastroenterology. 23, 32, p. 5994-6002 9 p.

Research output: Article

Open Access
Inflammatory Bowel Diseases
Meta-Analysis
Colon
Simethicone
Castor Oil